drugset / Trial / NCT04231513
A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants
RandomizedSequentialDouble-blindOther
Summary
The primary objective of this study is to evaluate the safety and tolerability of single and multiple intravenous infusions of E2814 in healthy adult participants.
Timeline
- Start
- 2019-12-16
- Primary completion
- 2023-03-09
- Completion
- 2023-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etalanetug | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.